-
FDA-Approved Isotope Therapies Provide 2 Options in the Castration-Resistant Prostate Cancer Armamentarium
15 Apr 2025 21:17 GMT
… is cabazitaxel [Jevtana]. When they … www.fda.gov/drugs/;resources-information-approved-drugs/fda- … treatment for castration-resistant prostate cancer with bone metastases. News release. Bayer HealthCare Pharmaceuticals … III trial comparing enzalutamide vs …
-
Prostate Cancer Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 150+ Companies Working in the Domain
15 Oct 2024 17:00 GMT
… , Tavanta Therapeutics, Madison Vaccines, Taiho Pharmaceutical, Kangpu Biopharmaceuticals, Arvinas, … prostate cancer drugs to improve the treatment landscape.
Promising … FDA approval for a Phase II/III trial … and Sanofi’s JEVTANA have also been approved …
-
Metastatic Prostate Cancer Market Report 2032: Epidemiology, Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight
25 Jun 2024 09:50 GMT
… , Madison Vaccines, Phosplatin Therapeutics, Hinova Pharmaceuticals, Bristol … treatment options. However, in recent years, a number of drugs, including JEVTANA … results in clinical trials with mCRPC patients … Cancer Current Treatment and Medical Practices
10. …
-
Dr Kyriakopoulos on Evaluating Biomarkers and Disease Progression with CTC Analysis in CHAARTED2 trial
28 Jun 2024 15:26 GMT
… phase 2 CHAARTED2 trial (NCT03419234) investigating cabazitaxel (Jevtana) plus abiraterone acetate … and potential predictive markers of treatment response and disease progression.
… biomarker studies in advancing personalized medicine in prostate cancer. The …
-
ARASENS Trial Demonstrates Significant Survival Benefits With Triplet Therapy in mHSPC
25 Jun 2024 20:54 GMT
… plus placebo. [Results from this trial] showed significant improvement or reduction … with non-ARPI treatment, mainly with docetaxel or cabazitaxel [Jevtana]. The median … better treatments. If these patients progress after having both classes of drugs …
-
Natco Pharma's partner Breckenridge Pharmaceutical gets FDA nod for prostate cancer treatment drug
25 Jul 2022 07:03 GMT
… powder used in the treatment of prostate cancer.
The … Drug Administration to Breckenridge Pharmaceutical, is for the abbreviated new drug … is the generic equivalent of Jevtana Kit of Sanofi.
… industry data, Natco said Jevtana Kit generated annual sales of …
-
ASX Health Stocks: Noxopharm jumps +50pc on mRNA vaccine results; Starpharma +25pc on Phase 2 study
18 Oct 2023 00:42 GMT
… Pharmaceuticals gets second FDA approval this year
Noxopharm up 50pc on mRNA vaccine … the Hudson Institute of Medical Research, in Melbourne.
… label clinical trial of DEP cabazitaxel.
The trial has … published data for competing drug Jevtana at the same dose …
-
2022 First Generic Drug Approvals
03 Mar 2023 17:52 GMT
… therapy to antidepressants for the treatment of major … /mL)
Breckenridge Pharmaceutical, Inc.
Jevtana (Cabazitaxel) Injection
6… /mL)
Indoco Remedies Limited
Vimpat (Lacosamide) Injection … partial reversal of opioid drug effects, including respiratory …
-
What are the medications for prostate cancer?
30 Jan 2023 13:31 GMT
… effects, treatment types, and more.
Doctors usually recommend medications for … cabazitaxel (Jevtana), also by IV.
Chemotherapy medications for … This infusion makes a vaccine unique to each person … , the Food and Drug Administration (FDA) warned that, although …
-
First Generic Drug Approvals
27 Sep 2022 17:00 GMT
… therapy to antidepressants for the treatment of major … /mL)
Breckenridge Pharmaceutical, Inc.
Jevtana (Cabazitaxel) Injection
6… /mL)
Indoco Remedies Limited
Vimpat (Lacosamide) Injection … partial reversal of opioid drug effects, including respiratory …
About
© 1995-2025